The application of sequential analysis for continuous post-market vaccine safety surveillance
10.3760/cma.j.cn112338-20240807-00482
- VernacularTitle:序贯分析在疫苗上市后安全性动态监测中的应用
- Author:
Zixuan LU
1
;
Musu LI
;
Jiahe PAN
;
Yiwen WU
;
Huilin LI
;
Er YU
;
Hongmei WO
;
Shaowen TANG
;
Yang ZHAO
;
Juncheng DAI
;
Honggang YI
Author Information
1. 南京医科大学公共卫生学院生物统计学系,南京 211166
- Publication Type:Journal Article
- Keywords:
Safety surveillance;
Adverse events;
Bayesian sequential analysis;
Pharmacovigilance
- From:
Chinese Journal of Epidemiology
2025;46(3):514-518
- CountryChina
- Language:Chinese
-
Abstract:
To explore the application of sequential analysis in post-market safety dynamic surveillance of vaccines. Under the dynamic monitoring data of vaccines post-market approval, this research introduces the fundamental principles of maximizing sequential probability ratio test (MaxSPRT) and Bayesian sequential analysis, employing R software. Through an example of dynamic safety monitoring data of vaccines post-market approval, we analyze using the MaxSPRT and Bayesian sequential analysis. The MaxSPRT identified a safety signal in week 4 ( P<0.05), while Bayesian sequential analysis indicated that the 95% highest density interval for the RR value at week 4 is 1.13-3.27, suggesting the first appearance of a safety signal at week 4. The MaxSPRT and Bayesian sequential analysis effectively leverage continuously accumulating dynamic monitoring data, thereby serving as a valuable method for post-market safety surveillance of vaccines.